Son y\u0131llarda meme kanserine y\u00f6nelik tedavi y\u00f6ntemlerinde devrim niteli\u011finde geli\u015fmeler ya\u015fan\u0131yor. Kanser tedavilerinde do\u011fal bile\u015fenlerin kullan\u0131m\u0131 ve nanoteknolojinin sundu\u011fu yenilik\u00e7i y\u00f6ntemler bir araya gelerek, etkin ve zarars\u0131z alternatifler geli\u015ftirilmesine olanak sa\u011fl\u0131yor. Bu ba\u011flamda, BMC Cancer\u2019da yay\u0131mlanan yeni bir \u00e7al\u0131\u015fma, solanin y\u00fckl\u00fc niosom nanopartik\u00fcller (SN-NP) arac\u0131l\u0131\u011f\u0131yla meme kanserine kar\u015f\u0131 umut vadeden bir tedavi yakla\u015f\u0131m\u0131n\u0131 ortaya koydu. Solanin, apoptoz (programlanm\u0131\u015f h\u00fccre \u00f6l\u00fcm\u00fc) ve metastaz s\u00fcre\u00e7lerini d\u00fczenleyen genler \u00fczerinde etkili olan do\u011fal bir glikoalkaloid bile\u015fik olarak biliniyor. Ancak, bu maddenin ila\u00e7 olarak kullan\u0131m\u0131, \u00e7\u00f6z\u00fcn\u00fcrl\u00fck problemleri ve y\u00fcksek dozlarda ortaya \u00e7\u0131kabilen toksisite nedeniyle uzun s\u00fcre s\u0131n\u0131rl\u0131 kald\u0131.<\/p>\n
Ara\u015ft\u0131rma ekibi, bu sorunlar\u0131 a\u015fmak i\u00e7in niosom ad\u0131 verilen, biyouyumlu ve non-iyonik y\u00fczey aktif maddelerden olu\u015fan nanovesik\u00fcller geli\u015ftirdi. Niosomlar, \u00f6zellikle hidrofobik bile\u015fenlerin etkin bi\u00e7imde ta\u015f\u0131nmas\u0131n\u0131 sa\u011flayan ta\u015f\u0131y\u0131c\u0131lard\u0131r. Solanin\u2019in bu ta\u015f\u0131y\u0131c\u0131 yap\u0131lar i\u00e7erisine kaps\u00fcllenmesi, hem hedefe y\u00f6nelik teslimat\u0131n\u0131 kolayla\u015ft\u0131r\u0131rken hem de biyoyararlan\u0131m\u0131n\u0131 \u00f6nemli oranda art\u0131r\u0131yor. B\u00f6ylece, kanserli h\u00fccrelere solaninin daha yo\u011fun ve kontroll\u00fc \u015fekilde ula\u015fmas\u0131 sa\u011flan\u0131yor. Elde edilen SN-NP\u2019ler, 50 ila 70 nanometre aras\u0131nda ortalama b\u00fcy\u00fckl\u00fc\u011fe ve %82\u2019nin \u00fczerinde y\u00fcksek kaps\u00fclleme verimlili\u011fine sahip.<\/p>\n
Partik\u00fcllerin homojenli\u011fi hakk\u0131nda bilgi veren polidispersite indeksi (PDI) 0.452 olarak \u00f6l\u00e7\u00fcld\u00fc. Bu de\u011fer, nanopartik\u00fcllerin nispeten stabil ve kullan\u0131ma uygun yap\u0131da oldu\u011funu g\u00f6steriyor. Solanin sal\u0131n\u0131m kineti\u011fi \u00e7al\u0131\u015fmalar\u0131 ise pH\u2019a ba\u011fl\u0131 \u00e7ift fazl\u0131 bir \u00f6zellik ortaya koydu. Hem fizyolojik (pH 7) hem de asidik (pH 5) ortamda \u00f6nce h\u0131zl\u0131 bir sal\u0131n\u0131m ger\u00e7ekle\u015firken ard\u0131ndan kontroll\u00fc ve uzun s\u00fcreli bir b\u0131rakma d\u00f6nemi ba\u015flad\u0131. Bu \u00e7ift fazl\u0131 sal\u0131n\u0131m profili, ilac\u0131n t\u00fcm v\u00fccuda aniden yay\u0131lmas\u0131n\u0131 engelleyerek sadece t\u00fcm\u00f6r mikrosisteminde etkili ve hedefe y\u00f6nelik kullan\u0131m\u0131n\u0131 m\u00fcmk\u00fcn k\u0131l\u0131yor. Uzun s\u00fcreli sal\u0131n\u0131m, kemoterapi etkinli\u011fini art\u0131rabilecek \u015fekilde t\u00fcm\u00f6r h\u00fccrelerine s\u00fcrekli ila\u00e7 maruziyeti sa\u011fl\u0131yor.<\/p>\n
SN-NP\u2019lerin h\u00fccresel etkileri MCF-7 h\u00fccre hatt\u0131 \u00fczerinde test edildi. Bu h\u00fccre hatt\u0131, \u00f6strojen resept\u00f6r pozitif meme kanserlerini temsil ediyor. MTT analizlerinde serbest haldeki solanin i\u00e7in belirlenen IC\u2085\u2080 de\u011feri 40 mg\/100 mL iken, nanopartik\u00fcllerle ta\u015f\u0131ma sonras\u0131nda bu de\u011fer 72 saatlik temas s\u00fcresi sonunda 5 mg\/100 mL\u2019ye d\u00fc\u015ft\u00fc. Bu %87.5 civar\u0131ndaki iyile\u015fme, nanoteknolojinin solaninin etkinli\u011fini art\u0131rmadaki kritik rol\u00fcn\u00fc ortaya koyuyor. Bu geli\u015fme, hem doz azalt\u0131m\u0131 yap\u0131labilme hem de yan etkilerin en aza indirgenmesi a\u00e7\u0131s\u0131ndan son derece anlaml\u0131.<\/p>\n
H\u00fccre \u00f6l\u00fcm\u00fc mekanizmas\u0131na yap\u0131lan ak\u0131\u015f sitometrisi analizleri, SN-NP uygulamas\u0131n\u0131n h\u00fccrelerin %30\u2019unu ge\u00e7 apoptotik evreye getirdi\u011fini, nekroz ise d\u00fc\u015f\u00fck oranda ger\u00e7ekle\u015fti\u011fini ortaya koydu. Bu durum, inflamasyon yaratma potansiyeli d\u00fc\u015f\u00fck, kontroll\u00fc ve tercih edilen bir programlanm\u0131\u015f h\u00fccre \u00f6l\u00fcm\u00fc \u015feklinin ger\u00e7ekle\u015fti\u011fini g\u00f6steriyor. Daha da \u00f6tesinde, h\u00fccre d\u00f6ng\u00fcs\u00fc analizlerinde, kanser h\u00fccrelerinin %81\u2019inin G0\/G1 faz\u0131nda durdu\u011fu tespit edildi. Bu da h\u00fccre proliferasyonunun durdurulmas\u0131 ve apoptozun te\u015fviki anlam\u0131na geliyor.<\/p>\n
Molek\u00fcler d\u00fczeyde yap\u0131lan kantitatif PCR analizleri, apoptotik Bax ve h\u00fccre adezyon molek\u00fcl\u00fc CDH-1 genlerinde \u00f6nemli art\u0131\u015f g\u00f6sterirken, antiapoptotik Bcl-2 ve matriks metalloproteinaz MMP2 genlerinde anlaml\u0131 bir azalma saptad\u0131. Bu gen d\u00fczenlemeleri, hem h\u00fccre \u00f6l\u00fcm\u00fcn\u00fc hem de metastaz potansiyelinin azalt\u0131lmas\u0131n\u0131 sa\u011fl\u0131yor. B\u00f6ylece, SN-NP\u2019lerin sadece t\u00fcm\u00f6r h\u00fccrelerine \u00f6ld\u00fcr\u00fcc\u00fc etkisi olmad\u0131\u011f\u0131, ayn\u0131 zamanda h\u00fccrelerin yay\u0131lma ve invazyon \u00f6zelliklerini de zay\u0131flatt\u0131\u011f\u0131 netle\u015fiyor.<\/p>\n
SN-NP tasar\u0131m\u0131, yaln\u0131zca solanin ta\u015f\u0131ma g\u00f6revi \u00fcstlenmekle kalmay\u0131p, ayn\u0131 zamanda hedefe y\u00f6nelik ve kontroll\u00fc sal\u0131n\u0131m sunmas\u0131yla ila\u00e7 penceresini en \u00fcst d\u00fczeye \u00e7\u0131kar\u0131yor. Bu durum, sistemik yan etkilerin azalmas\u0131n\u0131 sa\u011flar ve toksisite riskini minimize eder. Nanopartik\u00fcllerin i\u00e7indeki solanin, t\u00fcm\u00f6r mikrosistemine \u00f6zg\u00fc ko\u015fullar alt\u0131nda s\u00fcrekli sal\u0131narak, terap\u00f6tik etkinin artmas\u0131n\u0131 destekliyor. Niosomlar\u0131n biyouyumlulu\u011fu ve \u00e7e\u015fitlendirilebilir yap\u0131s\u0131, bu ta\u015f\u0131y\u0131c\u0131lar\u0131n gelecekte farkl\u0131 hidrofobik molek\u00fcllerle kullan\u0131lmas\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7\u0131yor.<\/p>\n
Bu geli\u015fmeler, sadece solanin bazl\u0131 tedaviler i\u00e7in de\u011fil, genel kanser nanoterapisi paradigmas\u0131 i\u00e7in de \u00f6nemli ipu\u00e7lar\u0131 sunuyor. Niosomlar\u0131n esnek tasar\u0131m\u0131, farkl\u0131 ila\u00e7 molek\u00fcllerinin kaps\u00fcllenmesi, sal\u0131n\u0131m kinetiklerinin ayarlanmas\u0131 ve h\u00fccre i\u00e7i hedeflemeyi m\u00fcmk\u00fcn k\u0131lmas\u0131, kanser tedavisinde yeni ufuklar a\u00e7\u0131yor. \u00c7ok y\u00f6nl\u00fc laboratuvar analizleri, \u00e7al\u0131\u015fmalar\u0131n g\u00fcvenilirli\u011fini ve terap\u00f6tik potansiyelini g\u00fc\u00e7lendiriyor.<\/p>\n
Do\u011fal kaynakl\u0131 biyoaktif molek\u00fcllerle nanoteknolojinin entegrasyonu, kanser terapilerinde yan etkisiz, y\u00fcksek etkinlikli yeni nesil ila\u00e7lar\u0131n geli\u015ftirilmesine zemin haz\u0131rl\u0131yor. Solanin, uygulamadaki zorluklar\u0131 nanomateryal deste\u011fi ile a\u015farak tekrar klinik ilgi oda\u011f\u0131 haline gelmi\u015f durumda. Bu sayede, hem ila\u00e7 direnci hem de sistemik toksisite problemlerine \u00e7\u00f6z\u00fcm olabilecek ta\u015f\u0131y\u0131c\u0131 sistemler g\u00fcndeme geliyor.<\/p>\n
\u00d6strojen resept\u00f6r pozitif meme kanserlerinde \u00f6zellikle alternatif veya tamamlay\u0131c\u0131 tedavi ihtiya\u00e7lar\u0131 artt\u0131k\u00e7a, SN-NP gibi nanoform\u00fclasyonlar klinik tedavilerde yerini alabilir. Mevcut kemoterapi rejimleri ile kombine edildi\u011finde, doz azalt\u0131m\u0131 ve yan etkilerin hafifletilmesi m\u00fcmk\u00fcn olabilir. T\u00fcm d\u00fcnyada meme kanseri insidans\u0131n\u0131n artmas\u0131 ve tedavi maliyetlerinin y\u00fcksekli\u011fi, yeni teknolojilerin klinik kullan\u0131m\u0131n\u0131 zorunlu k\u0131l\u0131yor.<\/p>\n
Ara\u015ft\u0131rman\u0131n \u00f6n\u00fcnde, SN-NP\u2019lerin in vivo etkinli\u011fi, farmakokinetik \u00f6zellikleri, dokulara da\u011f\u0131l\u0131m\u0131 ve uzun d\u00f6nem g\u00fcvenlik analizleri bulunuyor. \u00d6n klinik fazda ba\u015far\u0131l\u0131 sonu\u00e7lar al\u0131nmas\u0131 halinde, klinik denemelere ge\u00e7mek i\u00e7in sa\u011flam bir alt yap\u0131 olu\u015fturulacak. Bu umut verici geli\u015fmeler, solanin bazl\u0131 nanoterapilerin \u00f6n\u00fcm\u00fczdeki y\u0131llarda meme kanseri alan\u0131nda \u00f6nemli bir tedavi se\u00e7ene\u011fi olarak kendini g\u00f6stermesini sa\u011flayabilir.<\/p>\n
Sonu\u00e7 olarak, nanoteknolojik yakla\u015f\u0131mlar arac\u0131l\u0131\u011f\u0131yla do\u011fal bile\u015fenlerin yenilik\u00e7i tedavilere d\u00f6n\u00fc\u015ft\u00fcr\u00fclmesi hem biyoloji hem de malzeme bilimi a\u00e7\u0131s\u0131ndan b\u00fcy\u00fck bir ba\u015far\u0131d\u0131r. Solanin y\u00fckl\u00fc niosom nanopartik\u00fcller, hedef odakl\u0131, etkili ve toksisitesi d\u00fc\u015f\u00fck meme kanseri tedavisinde yeni bir d\u00f6nemin habercisidir. Kanser hastalar\u0131 i\u00e7in umut verici bu ara\u015ft\u0131rma, multidisipliner \u00e7al\u0131\u015fmalar\u0131n tedavi protokollerine adapte edilmesi yolunda \u00f6nemli bir kilometre ta\u015f\u0131d\u0131r.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Web References<\/strong>: Doi Referans<\/strong>: Resim Credits<\/strong>: Anahtar Kelimeler<\/strong>: Son y\u0131llarda meme kanserine y\u00f6nelik tedavi y\u00f6ntemlerinde devrim niteli\u011finde geli\u015fmeler ya\u015fan\u0131yor. Kanser tedavilerinde do\u011fal bile\u015fenlerin kullan\u0131m\u0131 ve nanoteknolojinin sundu\u011fu yenilik\u00e7i y\u00f6ntemler bir araya gelerek, etkin ve zarars\u0131z alternatifler geli\u015ftirilmesine olanak sa\u011fl\u0131yor. Bu ba\u011flamda, BMC Cancer\u2019da yay\u0131mlanan yeni bir \u00e7al\u0131\u015fma, solanin y\u00fckl\u00fc niosom nanopartik\u00fcller (SN-NP) arac\u0131l\u0131\u011f\u0131yla meme kanserine kar\u015f\u0131 umut vadeden bir tedavi yakla\u015f\u0131m\u0131n\u0131 ortaya koydu….<\/p>\n","protected":false},"author":1,"featured_media":5590,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[7320,7317,7318,7319,7316],"tmauthors":[],"class_list":{"0":"post-5589","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-mcf-7-hucre-hattinda-nanopartikul-etkileri","9":"tag-meme-kanseri-tedavisinde-dogal-bilesik-kullanimi","10":"tag-nanoteknoloji-ile-hedefe-yonelik-ilac-tasima","11":"tag-ph-duyarli-kontrollu-ilac-salinim-sistemleri","12":"tag-solanin-yuklu-niosom-nanopartikuller"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/05\/Solanin-Yuklu-Nanopartikullerle-Meme-Kanseri-Tedavisi-1747052117.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=5589"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5589\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/5590"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=5589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=5589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=5589"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=5589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMeme kanserinde solanin y\u00fckl\u00fc niosom nanopartik\u00fcllerin anticancer ve antimetastatik etkilerinin ara\u015ft\u0131r\u0131lmas\u0131.<\/p>\n
\nA potential new strategy for BC treatment: NPs containing solanine and evaluation of its anticancer and antimetastatic properties.<\/p>\n
\nhttps:\/\/doi.org\/10.1186\/s12885-025-14249-y<\/p>\n
\nhttps:\/\/doi.org\/10.1186\/s12885-025-14249-y<\/p>\n
\nScienmag.com<\/p>\n
\nanticancer properties of solanine, biocompatible nanocarriers for cancer, breast cancer treatment innovations, encapsulation efficiency in nanoparticles, engineered nanoscale carriers for drugs, gene expression modulation in cancer, metastasis regulation in breast cancer, nanotechnology in cancer therapy, overcoming solubility challenges in therapeutics, solanine-loaded niosome nanoparticles, targeted drug delivery systems, therapeutic applications of glycoalkaloids<\/p>\n","protected":false},"excerpt":{"rendered":"